6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
申请人:Arnold Lee D.
公开号:US20090118499A1
公开(公告)日:2009-05-07
Compounds of the formula
and pharmaceutically acceptable salts thereof, wherein X
1
, X
2
, X
3
, X
4
, X
5
, X
6
, X
7
, R
1
, and Q
1
are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.